Camford Capital logo

Camford Capital

North America, California, United States, Palo Alto

Description

Camford Capital is a venture capital firm that invests in Enterprise, Consumer, FinTech, and Healthcare companies.

Investor Profile

Camford Capital has made 10 investments, with 0 in the past 12 months and 30% as lead.

Stage Focus

  • Series A (40%)
  • Seed (30%)
  • Series B (20%)
  • Series D (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Biopharma
  • Medical
  • Pharmaceutical
  • Machine Learning
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Camford Capital frequently co-invest with?

BeiGene
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
ANRI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
8VC
North America, California, United States, San Francisco
Co-Investments: 2
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 2
Intuitive Ventures
North America, California, United States, Sunnyvale
Co-Investments: 2
Cancer Research Institute
North America, New York, United States, New York
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

What are some of recent deals done by Camford Capital?

Totus Medicines

Cambridge, Massachusetts, United States

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

BiopharmaBiotechnologyMedical
Series BDec 15, 2023
Amount Raised: $66,000,000
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series BJul 19, 2023
Amount Raised: $32,000,000
Lavita

San Francisco, California, United States

Lavita is a blockchain-AI based next generation healthcare platform.

Artificial Intelligence (AI)BlockchainHealth Care
SeedMay 10, 2023
Amount Raised: $5,000,000
FEDML

Palo Alto, California, United States

SaaS, PaaS, MLaaS (machine learning as a service)

Artificial Intelligence (AI)Machine LearningSoftwareWeb3
SeedMar 28, 2023
Amount Raised: $6,000,000
Vevo Therapeutics

San Francisco, California, United States

Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.

Artificial Intelligence (AI)BiotechnologyTherapeutics
SeedDec 8, 2022
Amount Raised: $12,000,000
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series AOct 17, 2022
Amount Raised: $26,000,000
Carbon Biosciences

Lexington, Massachusetts, United States

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

BiotechnologyProduct ResearchTherapeutics
Series AJun 21, 2022
Amount Raised: $38,000,000
Totus Medicines

Cambridge, Massachusetts, United States

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

BiopharmaBiotechnologyMedical
Series ADec 9, 2021
Amount Raised: $40,000,000
Strand Therapeutics

Cambridge, Massachusetts, United States

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

BiotechnologyLife SciencePharmaceuticalTherapeutics
Series AJun 23, 2021
Amount Raised: $52,000,000
CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series DDec 10, 2020
Amount Raised: $47,000,000